INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2015

D-allulose is a zero-calorie rare sugar that attenuates postprandial glucose levels in healthy and borderline diabetic subjects.

This review discusses the physiological functions and potential therapeutic role of the zero-calorie functional sweetener D-allulose in managing obesity and type 2 diabetes mellitus. Human trials cited in the review demonstrated that D-allulose attenuates postprandial glucose levels in healthy subjects and in individuals with borderline diabetes. In cell culture and animal models, D-allulose demonstrated anti-hyperlipidemic, anti-hyperglycemic, and anti-inflammatory properties, with rapid elimination in rat urine within 24 hours.

Study type
Narrative review
Who was studied
Healthy and borderline diabetic human subjects, as well as rodent and cell models
What was measured
Effects on postprandial glucose levels, obesity, and type 2 diabetes mellitus

THE PAPER

Rare sugar D-allulose: Potential role and therapeutic monitoring in maintaining obesity and type 2 diabetes mellitus.

Hossain A, Yamaguchi F, Matsuo T, Tsukamoto I, Toyoda Y, Ogawa M, Nagata Y, Tokuda M. Pharmacol Ther, 2015.

PubMed 26297965 ↗DOI 10.1016/j.pharmthera.2015.08.004 ↗

Heart & arteriesDiabetes & blood sugarWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.